Literature DB >> 30409855

Brain MR Imaging Findings in Woodhouse-Sakati Syndrome.

A H Abusrair1, S Bohlega2, A Al-Semari1, F S Al-Ajlan1, K Al-Ahmadi3, B Mohamed1, A AlDakheel1.   

Abstract

BACKGROUND AND
PURPOSE: Woodhouse-Sakati syndrome is a rare autosomal recessive disorder characterized by hypogonadism, alopecia, diabetes mellitus, and progressive extrapyramidal signs. The disease is caused by biallelic pathogenic variants in the DCAF17 gene. The purpose of this study was to describe the spectrum of brain MR imaging abnormalities in Woodhouse-Sakati syndrome.
MATERIALS AND METHODS: We reviewed brain MR images of 26 patients with a clinical and genetic diagnosis of Woodhouse-Sakati syndrome (12 males, 14 females; age range, 16-45 years; mean age, 26.6 years). Follow-up studies were conducted for 6 patients.
RESULTS: All patients had abnormal MR imaging findings. The most common abnormalities were a small pituitary gland (76.9%), pronounced basal ganglia iron deposition (73%), and white matter lesions in 69.2%. White matter lesions showed frontoparietal and periventricular predominance. All white matter lesions spared subcortical U-fibers and were nonenhanced. Prominent perivascular spaces (15.3%) and restricted diffusion in the splenium of the corpus callosum (7.6%) were less frequent findings. Follow-up studies showed expansion of white matter lesions with iron deposition further involving the red nucleus and substantia nigra. Older age was associated with a more severe degree of white matter lesions (P < .001).
CONCLUSIONS: Small pituitary gland, accentuated iron deposition in the globus pallidus, and nonenhancing frontoparietal/periventricular white matter lesions were the most noted abnormalities seen in our cohort. The pattern and extent of these findings were observed to correlate with older age, reflecting a possible progressive myelin destruction and/or axonal loss. The presence of pituitary hypoplasia and white matter lesions can further distinguish Woodhouse-Sakati syndrome from other neurodegenerative diseases with brain iron accumulation subtypes.
© 2018 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2018        PMID: 30409855     DOI: 10.3174/ajnr.A5879

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  8 in total

1.  Endocrine Abnormalities in a Case of Neurodegeneration with Brain Iron Accumulation.

Authors:  Ghazal Haeri; Fahimeh Haji Akhoundi; Afagh Alavi; Siamak Abdi; Mohammad Rohani
Journal:  Mov Disord Clin Pract       Date:  2020-06-24

Review 2.  Cerebral Iron Deposition in Neurodegeneration.

Authors:  Petr Dusek; Tim Hofer; Jan Alexander; Per M Roos; Jan O Aaseth
Journal:  Biomolecules       Date:  2022-05-17

Review 3.  Movement Disorders Associated with Hypogonadism.

Authors:  Paulina Gonzalez-Latapi; Mario Sousa; Anthony E Lang
Journal:  Mov Disord Clin Pract       Date:  2021-07-29

Review 4.  Metals and Metal-Nanoparticles in Human Pathologies: From Exposure to Therapy.

Authors:  Joanna Izabela Lachowicz; Luigi Isaia Lecca; Federico Meloni; Marcello Campagna
Journal:  Molecules       Date:  2021-11-02       Impact factor: 4.411

5.  Woodhouse-Sakati syndrome (WSS): A case report of 3 Saudi sisters with urogenital anomalies.

Authors:  Mariam S Alharbi
Journal:  Saudi Med J       Date:  2021-11       Impact factor: 1.422

6.  Woodhouse-Sakati Syndrome Presenting With Psychotic Features After Starting Trihexyphenidyl: A Case Report.

Authors:  Mohammed A Aljaffer; Ahmad H Almadani; Mohammad AlMutlaq; Abdulaziz Alhammad; Ahmed S Alyahya
Journal:  Cureus       Date:  2022-08-01

7.  Radiological Findings of Woodhouse-Sakati Syndrome: Cases Reported From Saudi Arabia.

Authors:  Arwa M Alzahrani; Lamis O Alsuwailem; Rinad M Alghoraiby; Fahad B Albadr; Yahya M Alaseri
Journal:  Cureus       Date:  2022-08-29

Review 8.  Brain MRI Pattern Recognition in Neurodegeneration With Brain Iron Accumulation.

Authors:  Jae-Hyeok Lee; Ji Young Yun; Allison Gregory; Penelope Hogarth; Susan J Hayflick
Journal:  Front Neurol       Date:  2020-09-10       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.